N-Alkenyl and cycloalkyl carbamates as dual acting histamine H3 and H4 receptor ligands
摘要:
Previous studies have shown that several imidazole derivatives posses affinity to histamine H-3 and H-4 receptors. Continuing our study on structural requirements responsible for affinity and selectivity for H-3/H-4 receptor subtypes, two series of 3-(1H-imidazol-4-yl) propyl carbamates were prepared: a series of unsaturated alkyl derivatives (1-9) and a series possessing a cycloalkyl group different distances to the carbamate moiety (10-13). The compounds were tested for their affinities at the human histamine H3 receptor, stably expressed in CHO-K1 cells. Compounds 1, 2, 5-7, 10-13 were investigated for their affinities at the human histamine H-4 receptor co-expressed with G alpha(i2) and G beta(1)gamma(2) subunits in Sf9 cells. To expand the pharmacological profile, compounds were further tested for their H3 receptor antagonist activity on guinea pig ileum and in vivo after oral administration to mice. All tested compounds exhibited good affinity for the human histamine H-3 receptor with K-i values in the range from 14 to 194 nM. All compounds were active in vivo after peroral administration (p.o.) to Swiss mice, thus demonstrating their ability to cross the blood-brain barrier. The most potent H-3 receptor ligand of these series was compound 5, 3-(1H-imidazol-4-yl) propyl pent-4-enylcarbamate with the highest affinity (K-i = 14 nM). Additionally, compound 3 showed remarkable central nervous system (CNS) H3R activity, increasing the N-tau-methylhistamine levels in mice with an ED50 value of 0.55 mg/kg, p.o. evidencing therefore, a twofold increase of inverse agonist/antagonist potency compared to the reference inverse agonist/antagonist thioperamide. In this study, the imidazole propyloxy carbamate moiety was kept constant. The different lipophilic moieties connected to the carbamate functionality in the eastern part of the molecule had a range of influences on the human H-4 receptor affinity (154-1326 nM). (C) 2011 Elsevier Ltd. All rights reserved.
A Cooperative Strategy for the Highly Selective Intermolecular Oxycarbonylation Reaction of Alkenes using a Palladium Catalyst
作者:Ming Li、Feng Yu、Xiaoxu Qi、Pinhong Chen、Guosheng Liu
DOI:10.1002/anie.201607248
日期:2016.10.24
terminal and internal alkenes has been designed. The electrophilic reagent, hypervalent iodine, plays a key role in this process by activating the alkene C=C bond for nucleophilic addition of the palladiumcatalyst. This process generates an iodonium‐containing palladium species which undergoes CO insertion. The new approach, intermolecular oxycarbonylaton reactions of alkenes, has been achieved and
Stereoselective iron-catalyzed alkyne hydrogenation in ionic liquids
作者:Tim N. Gieshoff、Alice Welther、Michael T. Kessler、Martin H. G. Prechtl、Axel Jacobi von Wangelin
DOI:10.1039/c3cc49679a
日期:——
Iron(0) nanoparticles in ionic liquids (ILs) have been shown to catalyse the semi-hydrogenation of alkynes. In the presence of a nitrile-functionalised IL or acetonitrile, stereoselective formation of (Z)-alkenes was observed. The biphasic solvent system allowed facile separation and re-use of the catalyst.
[EN] EFFICIENT METHODS FOR Z- OR CIS-SELECTIVE CROSS-METATHESIS<br/>[FR] PROCÉDÉS EFFICACES DE MÉTATHÈSE CROISÉE Z-SÉLECTIVE OU CIS-SÉLECTIVE
申请人:TRUSTEES BOSTON COLLEGE
公开号:WO2011097642A1
公开(公告)日:2011-08-11
The present invention generally relates to methods for performing metathesis reactions, including cross-metathesis reactions. Methods described herein exhibit enhanced activity and stereoselectivity, relative to known methods, and are useful in the synthesis of a large assortment of biologically and therapeutically significant agents.